HomeHealth TopicsSocial Family IssuesUnderstanding Medical Research
Back to Social Family Issues
Understanding Medical Research
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Social Family Issues

Understanding Medical Research

New medical findings are essential tools for managing your health, but it is important to evaluate them critically to understand their true significance.

The Challenge of Interpreting Research

While scientific journals provide valuable data, news reports about these studies may not always provide the full context. It is important to be aware of common limitations in reporting:

  • News stories may fail to explain how a study fits into the broader scientific picture.
  • Results from different studies may appear to conflict due to variations in study design and the questions asked.
  • Small studies may be reported without highlighting the need for further research to confirm the findings.

Questions to Evaluate Medical Findings

When you hear about a new medical breakthrough, consider these questions to better evaluate the information:

  • Study Subjects: Was the study conducted in animals or humans? Animal results do not always translate to humans.
  • Relevance: Were the participants similar to you in terms of age, race, or sex?
  • Scale: How large was the study? Larger studies generally provide more reliable results.
  • Duration: How long did the study last? Long-term studies are necessary to determine the benefits or risks of medicines.
  • Study Type: What kind of study was it? Clinical trials, particularly randomized controlled trials, provide the clearest information regarding safety and effectiveness by preventing bias.
  • Context: Where was the research conducted?
  • Safety: If a new treatment was tested, what were the side effects and how common were they?
  • Consistency: How do these results compare to previous studies? Conflicting results often necessitate further research.
  • Funding: Who paid for the research? Potential financial conflicts of interest can influence study outcomes.
  • Reporting: Who is reporting the results, and do they have a potential bias?

Frequently Asked Questions

There’s no universal “magic number,” but larger sample sizes increase statistical power and reduce random error. For common outcomes, thousands of participants are often needed; for rare events, even larger cohorts may be required. More important than size alone is whether the study performed a proper power calculation, enrolled participants representative of the target population, and reported confidence intervals. A well‑designed small RCT can be trustworthy, while a huge poorly designed study may still be misleading.
Look for key phrases in the report: “randomized,” “double‑blind,” “placebo‑controlled,” or “clinical trial” usually indicate an RCT. If the article mentions “cohort,” “case‑control,” “registry data,” or “observational,” it’s likely not randomized. RCTs are considered the gold standard because random assignment reduces bias, whereas observational studies can suggest associations but cannot prove causation.
Differences often stem from study design (RCT vs. observational), sample size, patient population, dosage, duration of follow‑up, and endpoints measured. Small or short‑term studies may miss rare side effects, while larger, longer trials provide more reliable estimates. Additionally, variations in inclusion criteria (e.g., age, comorbidities) can make results appear contradictory. Systematic reviews or meta‑analyses that pool multiple studies help clarify the overall trend.
If the sponsor is a pharmaceutical or device company that stands to profit from a positive result, scrutinize the methodology: Are the investigators independent? Is the study registered prospectively (e.g., on ClinicalTrials.gov)? Are all pre‑specified outcomes reported, or does the paper highlight only favorable secondary outcomes? Look for statements about data access and whether an independent data‑monitoring board was used.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss